Cargando…
Enhanced Specific Activity by Multichelation of Exendin-3 Leads To Improved Image Quality and In Vivo Beta Cell Imaging
[Image: see text] Glucagon-like peptide-1 receptor (GLP-1R) targeting using radiolabeled exendin is a promising approach to noninvasively visualize and determine beta cell mass (BCM), which could help to unravel the pathophysiology of diabetes. However, saturation of the GLP-1R on beta cells occurs...
Autores principales: | Joosten, Lieke, Brom, Maarten, Peeters, Hanneke, Heskamp, Sandra, Béhé, Martin, Boerman, Otto, Gotthardt, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2017
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150723/ https://www.ncbi.nlm.nih.gov/pubmed/29226686 http://dx.doi.org/10.1021/acs.molpharmaceut.7b00853 |
Ejemplares similares
-
The effect of purification of Ga-68-labeled exendin on in vivo distribution
por: Brom, Maarten, et al.
Publicado: (2016) -
(111)In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass
por: Brom, Maarten, et al.
Publicado: (2015) -
Strain Differences Determine the Suitability of Animal Models for Noninvasive In Vivo Beta Cell Mass Determination with Radiolabeled Exendin
por: Willekens, Stefanie M. A., et al.
Publicado: (2016) -
(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
por: Brom, Maarten, et al.
Publicado: (2010) -
Exendin‐4 analogs in insulinoma theranostics
por: Jansen, Tom.J.P., et al.
Publicado: (2019)